Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements
Sponsor: Aleris-Hamlet Hospitaler København
This NA trial investigates Atrial Fibrillation and is currently completed. Aleris-Hamlet Hospitaler København leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Completed NA
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aleris-Hamlet Hospitaler København
- Cortrium
- University Hospital Bispebjerg and Frederiksberg
For direct contact, visit the study record on ClinicalTrials.gov .